Revenue
attach_money2,378M USD
YoY +5.1%
RPRXRoyalty Pharma plc$ --
Royalty Pharma plc
RPRX
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart1,560M USD
YoY +20.7%
Net Income
verified771M USD
YoY -10.2%
EPS
pie_chart2.33USD
YoY +21.4%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress11.2%Below Target
Revenue Progress631M
Revenue Forecast3.3B
Net Income Progress295M
Net Income Forecast2.6B
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.